CRY News and Press, CryoLife Inc.

CryoLife Announces Corporate Rebranding and Changes Name to Artivion Artivion to Host Investor & Analyst Day on March 23, 2022 PR Newswire ATLANTA , Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company f...

CryoLife's (CRY +4.7%) director Anthony B. Semedo has bought 19,992 shares of the company, worth $347K. The shares are purchased at $17.36 per share. SEC Filing. A look at the company's shareholding composition:  Previously (Nov. 4): CryoLife EPS misses by $0.06, misses on revenue For ...

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum PR Newswire ATLANTA , N...

CryoLife, Inc. (CRY) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants J. Patrick Mackin - Chairman, President and Chief Executive Officer D. Ashley Lee - EVP, Chief Operating Officer, and Chief Financial Officer Conference Call Participants Suraj Kalia - Oppen...

Image source: The Motley Fool. Cryolife Inc (NYSE: CRY) Q3 2021 Earnings Call Nov 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cryolife Inc (CRY) Q3 2021 Earnings Call Transcript

CryoLife (NYSE:CRY): Q3 Non-GAAP EPS of -$0.03 misses by $0.06; GAAP EPS of $0.26 beats by $0.28. Revenue of $72.2M (+10.9% Y/Y) misses by $0.2M. Press Release For further details see: CryoLife EPS misses by $0.06, misses on revenue

CryoLife Reports Third Quarter 2021 Financial Results PR Newswire ATLANTA , Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 ...

CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results PR Newswire ATLANTA , Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease,...

Anthony Semedo Joins CryoLife Board of Directors PR Newswire ATLANTA , Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Seme...

CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire ATLANTA , Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that i...